As a mage, I just want to pursue the truth

Chapter 37 Musk and Neuralink
Ke Chuang Bio's brain-computer connection technology leads in several aspects. First, the recognition rate is high, second, the recognition range is wide, and third, the number of electrode points required is small.

Products like those released by Neuralink, a company owned by Musk, require the implantation of more than 3,000 electrodes in the brain to detect neuronal activity.

Ke Chuang Bio does not need to implant electrodes, and only needs about one hundred electrodes. Its recognition success rate is also far higher than that of its peers. The gap is the gap between laboratory products and commercially available products.

In the field of biomedicine, the gap between Zheng Li and Bluestar Biomedicine is even greater than the gap between the Nobel Prize winner in biology and a high school student.

The key to the brain-computer connection that Zheng Li came up with is to solve the problem of too many neuronal signals in the brain. The key is how to filter out unnecessary neuronal signals through filtering algorithms, leaving only the neural signals that I need to identify.

Ren Yong was not frustrated by Cheng Gang's rejection. The most important reason for his visit this time was to express his gratitude and his hope to maintain a long-term cooperative relationship with Kechuang Bio.

Regarding the hope that Kechuang Biotechnology will refuse to authorize Samsung and Apple, it would be best if it can be achieved, but it doesn’t matter if it is not possible.

Because if he were Ke Chuang Bio, he wouldn't do that either.

He just regretted not investing in Ke Chuang Bio's Series A round of investment.

Now the domestic venture capital circle is talking about the legend that Lei Jun spent 50 million to get 10% of the shares of Ke Chuang Biotechnology. Everyone says that Lei Jun is very lucky, as the 50 million he invested increased a thousand times in less than two years.

The success of Sci-Tech Bio has also led to some biopharmaceutical companies with core technologies easily obtaining large investments in recent years. For example, after failing to participate in the second round of investment in Sci-Tech Bio, China Merchants Bank International invested in five biopharmaceutical companies.

One of the biopharmaceutical companies announced that it would develop an industrialized endorphin synthesis route that was different from that of Ke Chuang Bio.

Ren Yong: "I fully understand your company's decision. In the future, Huawei hopes to cooperate with your company in the field of brain-computer connection. Brain-computer connection can be applied not only on the personal side, but also on Industry 4.0."

After its mobile phone business stagnated due to the blockade and its market share continued to decline, Huawei hoped that smart industry would become its next profit growth point.

Cheng Gang nodded and said, "I will report this to Director Zheng."

Cheng Gang knew that he was not Zheng Li's direct line, so he was very cautious in his position as general manager of Ke Chuang Bio and would report any important matters to Zheng Li.

Ren Yong continued, "When will Director Zheng return to Gusu? Before I came, Director Yu expressed his hope to have a face-to-face conversation with Director Zheng."

Cheng Gang replied: "Mr. Zheng will not return to China in the near future. First, due to the impact of the epidemic, he will be quarantined for at least fourteen days. Mr. Zheng is a workaholic. If he is quarantined in a hotel for fourteen days, he might go crazy."

"In addition, Kechuang Biotechnology's current brain-computer connection technology is only most effective for Chinese-speaking yellow people."

"Mr. Zheng is currently conducting research and development on brain-computer connections in other mainstream languages."

An article speculating on the impact of language on brain nerve signals was published in the latest issue of Nature.

Although Zheng Li's speculation is not supported by sufficient experimental data, Zheng Li is now a top expert in the field of brain-computer connection, so his speculation can be published.

Thousands of miles away from Suzhou, in California, America, Neuralink has obtained Ke Chuang Bio's testing products through Apple.

After they reported the test data to Musk, Musk, known as Iron Man, became furious:
“You told me in 18 that we wanted to operate the iPhone through brain-computer connection. Three years have passed, and our laboratory products are still imperfect.”

Neuralink is Musk's brain-computer connection company. Its head said in a speech at the California Academy of Sciences on July 19, 7 that they plan to develop technology that allows people to control iPhones directly with their brain consciousness.

"The accuracy of our laboratory's brain-computer connection products on mobile phones is less than 50%." "The scientific and innovative biotechnology from China has been implemented, and what you see before your eyes is their brain-computer connection technology!"

"The Chinese can achieve a 99 percent recognition accuracy using this technology, and they don't have to implant damn electrodes into the brain!"

"Your idea is to develop a damn CPU and connect it to the brain through a wire thinner than a human hair."

"What's even more ridiculous is how these sensors, which are mounted on the surface of the skull, will transmit information to the wearable computer 'Link' located behind the ear."

"When you see the technology of Kechuang Biotechnology, don't you feel ashamed?"

"The solution you proposed is so backward and ridiculous. What's more important is that you haven't even implemented such backward technology yet!"

Neuralink plans to use this method so that the brain can be connected to the iPhone through an APP.

"Chinese companies can control iPhones with their minds by simply wearing headphones. What about us? We want to implant the damn sensors into the surface of the skull."

"Don't you think this is cyberpunk? Very cool! Those drug addicts who have taken dama will not hesitate to cut a hole in their heads and implant our electrode sensors!"

Musk couldn't suppress his anger because he thought his company Neuralink was at the forefront of brain-computer connection.

It turned out that there was a Chinese company called Ke Chuang Biotechnology that I had never heard of before, and I couldn’t even see its taillights, Neuralink.

Hodak is the president of Neuralink, and he was scolded by Musk until he was sweating profusely.

Musk gives people the impression of being a passionate and friendly entrepreneur and businessman, but he is an absolute "tyrant" within the company.

Hodak explained: "I'm sorry, Kechuang Bio may have taken a completely different technological route from us. I just need a little time to catch up with them."

Musk asked: "Why are we still doing experiments on damn monkeys when the brain-computer connection of Kechuang Bio has been successfully commercialized?"

“When can we start human trials?”

Neuralink's previous brain-computer connection experiments have always been conducted on monkeys.

Hodak: "We haven't received FDA approval for human trials yet, so it may take some time."

Musk said helplessly: "Why do we have to conduct our experiments in America? Can't we set up a research and development center in Singapore like Sinovation Biotech and conduct experiments in Southeast Asia where the supervision is not so strict?"

Musk has read the information of Kechuang Biotechnology. He believes that an important reason why they are ahead of Neuralink is that they started human experiments very early.

Neuralink has never conducted any human trials.

Hodak explained: "Ours is an invasive brain-computer connection, and the supervision will be stricter on our method. Kechuang Bio's brain-computer connection is non-invasive."

(End of this chapter)